Brandtree

Who owns Neoretin?

Neoretin is owned by Cantabria Labs (Spain).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Cantabria Labs — Our story. Last checked .

Key facts

Current owner
Cantabria Labs reported
Owner HQ
🇪🇸 Spain, Madrid
Origin
🇪🇸 Spain
Category
Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
Last verified
· 1 sources

About Neoretin

Neoretin is the Cantabria Labs brand for skin with dark spots and hyperpigmentation, which the company calls the leading depigmenting brand in medical prescriptions. Its products combine patented actives aimed at the main causes of dark spots, including the RetinSphere technology the company acquired in 2006, and the range covers cleansers, eye-contour creams and emulsions developed with doctors and backed by clinical studies.

Ownership timeline of Neoretin

  1. Current owner Cantabria Labs [1] reported

Where Neoretin sits in Cantabria Labs

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Neoretin sits in Cantabria Labs Tree of 7 brands under Cantabria Labs. Cantabria Labs Neoretin Aktuva Biretix Endocare Heliocare Iraltone and 1 more

Open the full Cantabria Labs ownership tree →

See the full Cantabria Labs brand portfolio (7) →

Other brands owned by Cantabria Labs

Cantabria Labs controls 7 brands on Brandtree, 7 of them in personal care & beauty.

Also in personal care & beauty

All Cantabria Labs brands →

Other brands in dermocosmetics & clinical skin care, and who owns them

The 41 brands in dermocosmetics & clinical skin care on Brandtree belong to 21 owners. The largest is Ego Pharmaceuticals, with 9; Cantabria Labs has 4.

BrandOwnerOwner based in
DermAid Ego Pharmaceuticals 🇦🇺 Australia
CeraVe L'Oréal 🇫🇷 France
A-Derma Pierre Fabre 🇫🇷 France
Dermalogica Unilever 🇬🇧 United Kingdom
Minon Daiichi Sankyo Healthcare 🇯🇵 Japan
Alastin Galderma 🇨🇭 Switzerland
A-Solution Aekyung 🇰🇷 South Korea
Eucerin Beiersdorf 🇩🇪 Germany

Every brand in dermocosmetics & clinical skin care and its owner →

About the owner: Cantabria Labs

Cantabria Labs is a privately held company headquartered in Madrid, Spain. Brandtree records 7 brands under its control.

Cantabria Labs is a Spanish dermatological laboratory with an office in Madrid and laboratories in Santander and Madrid. By its own account it began as a small family-run laboratory based in Cantabria, and in 1994 it acquired 100% of Industrial Farmacéutica Cantabria; it later adopted the Cantabria Labs name. It makes medicines, cosmetics and food supplements, and sells its skin-care ranges under brand names of their own such as Heliocare, Endocare and Biretix. It also runs joint ventures with Rafa Nadal (NDL Pro-Health) and Sofía Vergara (Toty) and holds a stake in the veterinary company Stangest; none of those is listed here. The Inmunoferon food supplement is also left out because it is not a personal-care product.

Cantabria Labs: full profile, brands and acquisition history →

🇪🇸 Neoretin and other Spanish brands

Brandtree records a controlling owner for 119 brands that began in Spain. 55 of them (46%) are now controlled by a company headquartered in another country; Neoretin is not one of them.

All Spanish brands and who owns them →

Frequently asked questions

Who is the parent company of Neoretin?

The parent company of Neoretin is Cantabria Labs, a privately held company headquartered in Spain.

Is Neoretin Spanish?

Yes. Neoretin originated in Spain and its owner, Cantabria Labs, is also headquartered in Spain.

Is Neoretin still owned by Cantabria Labs?

Yes. As of 4 October 2026, Neoretin is still owned by Cantabria Labs. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Cantabria Labs — Our story — Cantabria Labs, Official document; retrieved 4 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.